Lasa Supergenerics Ltd - 540702 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements Regulations. 2015
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated basis, in the format specified as per accounting standards for the financial year ended 31st March, 2019. Lasa Supergenerics Ltd - 540702 - Outcome of Board Meeting
Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today has approved and adopted Re-stated Financial Statement for the year ended March 31, 2019 along with the annexures and notes thereto. Lasa Supergenerics Ltd - 540702 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm Shivam Sharma & Associates Company Secretaries 4 Name of the Certifying Individual Shivam Sharma 5Membership TypeACS 6 Membership Number 35727 7 CP No. 16558 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO Lasa Supergenerics Ltd - 540702 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLasa Supergenerics Ltd 2CINU24233MH2016PLC274202 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Nidhi Kulshrestha Designation: Company secretary and Compliance Officer EmailId: cs@lasalabs.com Name of the Chief Financial Officer: Ravi Shankar Kabra Designation: Chief Financial Officer EmailId: cs@lasalabs.com Date: 23/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of the India(Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of newspaper advertisement Lasa Supergenerics Ltd - 540702 - Statement Of Audited Financial Results For The Quarter And Year Ended March 31, 2019 Along With Auditors Report
Further to our letter dated May 9, 2019 vide Ref. No.: LASA/SE/19-20/007, we write to inform you that at the meeting held today at the Corporate Office of the Company which was commenced at 2.00 p.m. and concluded at 4.30 p.m. has considered, approved and took on record the Audited Financial Results for the Quarter and Year ended March 31, 2019 along with Statement of Assets and Liabilities for the year ended March 31, 2019 along with Audit Report and Declaration of unmodified opinion. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of newspaper advertisements. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2019 ,inter alia, to consider and approve and take on record Audited Financial Results of the Company along with the Auditor's Report for the Quarter and Year ended March 31, 2019, and/or to discuss any other business/matter with the permission of the Chair. Lasa Supergenerics Ltd - 540702 - Declaration With Respect To Non - Applicability Of Large Entities Framework Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November, 2018
Pursuant to SEBI Circular No.SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 for fund raising by issuance of debt securities by Large Entities and compliances thereof. We hereby submit that our Company is out of purview of Large Corporate category as per the applicability of framework provided in the aforesaid circular.